Canadian Institutes of Health Research logo of green stylized maple leaf
CIHR has launched this funding opportunity to support the development of knowledge syntheses, using an equity, diversity and inclusion lens, to assess the current state of knowledge and evidence base, and identify strengths and gaps in research areas related to the promotion of brain health and risk reduction for age-related cognitive impairment. This would include a specific focus on knowledge mobilization practices throughout the research process to increase the usefulness and uptake of findings to relevant stakeholders, including partners and knowledge users, as well as the creation of culturally appropriate, equitable and inclusive targeted KM products. 
  • Funding: Maximum of $100,000 for up to 1 year 
  • Registration Deadline: May 25, 2023
  • Full Application Deadline: June 22, 2023 
* Application due to ORIS/ Faculties (Ingrid Qemo) – June 8, 2023* More info

The goal of this funding opportunity is to advance the understanding about risk reduction and protective factors involved in promoting cognitive health and mitigating the changes that occur in the onset and progression of cognitive impairment and dementia in aging, while considering the intersection of different factors, including the social determinants of health and other structural and systemic barriers. The intent is also to build training and mentoring capacity for the next generation of researchers in the field.
  • Funding: Maximum amount per grant is $250,000 per year for a maximum of 3 years. 
  • Registration deadline: June 13, 2023
  • Application Deadline: July 12, 2023
*Application due to ORIS/ Faculties (Ingrid Qemo) – June 28, 2023* More info

The purpose of this funding opportunity is to advance a coordinated research program that addresses under-researched and high-priority areas of women’s health (ex. Diagnosis and treatment of endometriosis, early detection of ovarian cancer, early self-detection of breast cancer, treatment of gynecological conditions, treatment for premenopausal, menopausal and postmenopausal symptoms in cases where hormone therapy may not be suitable or desired, development of non-hormonal female contraceptives, and gender-affirming hormone therapies). This funding opportunity will support basic science and/or other types of preclinical studies that have the potential to make significant advancements in women’s health. Projects are expected to involve cells, tissues, body parts, and/or biomarkers. 
  •   Funding maximum amount per grant is $150,000 for up to one year
  •   Registration deadline: June 21, 2023
  •   Application deadline: July 19, 2023
*Application due to ORIS/ Faculties (Ingrid Qemo) – July 5, 2023* More info